These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27146673)

  • 1. Epigenetic changes mediated by polycomb repressive complex 2 and E2a are associated with drug resistance in a mouse model of lymphoma.
    Flinders C; Lam L; Rubbi L; Ferrari R; Fitz-Gibbon S; Chen PY; Thompson M; Christofk H; B Agus D; Ruderman D; Mallick P; Pellegrini M
    Genome Med; 2016 May; 8(1):54. PubMed ID: 27146673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphine leads to global genome changes in H3K27me3 levels via a Polycomb Repressive Complex 2 (PRC2) self-regulatory mechanism in mESCs.
    Muñoa-Hoyos I; Halsall JA; Araolaza M; Ward C; Garcia I; Urizar-Arenaza I; Gianzo M; Garcia P; Turner B; Subirán N
    Clin Epigenetics; 2020 Nov; 12(1):170. PubMed ID: 33168052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous epigenetic regulation of HACE1 in Burkitt- Lymphoma-derived cells.
    Bouzelfen A; Kora H; Alcantara M; Bertrand P; Latouche JB; Jardin F
    Leuk Res; 2017 Sep; 60():53-57. PubMed ID: 28651105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
    Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
    J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redistribution of H3K27me3 upon DNA hypomethylation results in de-repression of Polycomb target genes.
    Reddington JP; Perricone SM; Nestor CE; Reichmann J; Youngson NA; Suzuki M; Reinhardt D; Dunican DS; Prendergast JG; Mjoseng H; Ramsahoye BH; Whitelaw E; Greally JM; Adams IR; Bickmore WA; Meehan RR
    Genome Biol; 2013 Mar; 14(3):R25. PubMed ID: 23531360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of action and resistance in histone methylation-targeted therapy.
    Yamagishi M; Kuze Y; Kobayashi S; Nakashima M; Morishima S; Kawamata T; Makiyama J; Suzuki K; Seki M; Abe K; Imamura K; Watanabe E; Tsuchiya K; Yasumatsu I; Takayama G; Hizukuri Y; Ito K; Taira Y; Nannya Y; Tojo A; Watanabe T; Tsutsumi S; Suzuki Y; Uchimaru K
    Nature; 2024 Mar; 627(8002):221-228. PubMed ID: 38383791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative Proteomic Profiling Reveals PRC2-Dependent Epigenetic Crosstalk Maintains Ground-State Pluripotency.
    van Mierlo G; Dirks RAM; De Clerck L; Brinkman AB; Huth M; Kloet SL; Saksouk N; Kroeze LI; Willems S; Farlik M; Bock C; Jansen JH; Deforce D; Vermeulen M; Déjardin J; Dhaenens M; Marks H
    Cell Stem Cell; 2019 Jan; 24(1):123-137.e8. PubMed ID: 30472157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic alterations of the keratin 13 gene in oral squamous cell carcinoma.
    Naganuma K; Hatta M; Ikebe T; Yamazaki J
    BMC Cancer; 2014 Dec; 14():988. PubMed ID: 25527207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 5' regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cells.
    Szenthe K; Koroknai A; Banati F; Bathori Z; Lozsa R; Burgyan J; Wolf H; Salamon D; Nagy K; Niller HH; Minarovits J
    Biochem Biophys Res Commun; 2013 Apr; 433(4):489-95. PubMed ID: 23528241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma.
    Natsume A; Ito M; Katsushima K; Ohka F; Hatanaka A; Shinjo K; Sato S; Takahashi S; Ishikawa Y; Takeuchi I; Shimogawa H; Uesugi M; Okano H; Kim SU; Wakabayashi T; Issa JP; Sekido Y; Kondo Y
    Cancer Res; 2013 Jul; 73(14):4559-70. PubMed ID: 23720055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquine.
    Catalano R; Rocca R; Juli G; Costa G; Maruca A; Artese A; Caracciolo D; Tagliaferri P; Alcaro S; Tassone P; Amodio N
    Eur J Med Chem; 2019 Dec; 183():111715. PubMed ID: 31550663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryosectioning the intestinal crypt-villus axis: an ex vivo method to study the dynamics of epigenetic modifications from stem cells to differentiated cells.
    Vincent A; Kazmierczak C; Duchêne B; Jonckheere N; Leteurtre E; Van Seuningen I
    Stem Cell Res; 2015 Jan; 14(1):105-13. PubMed ID: 25590428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global histone H3 lysine 27 triple methylation levels are reduced in vessels with advanced atherosclerotic plaques.
    Wierda RJ; Rietveld IM; van Eggermond MC; Belien JA; van Zwet EW; Lindeman JH; van den Elsen PJ
    Life Sci; 2015 May; 129():3-9. PubMed ID: 25445221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABF-1 is frequently silenced by promoter methylation in follicular lymphoma, diffuse large B-cell lymphoma and Burkitt's lymphoma.
    Ushmorov A; Leithäuser F; Ritz O; Barth TF; Möller P; Wirth T
    Leukemia; 2008 Oct; 22(10):1942-4. PubMed ID: 18368067
    [No Abstract]   [Full Text] [Related]  

  • 15. Epigenetic regulation of the ABCB1 gene in drug-sensitive and drug-resistant lymphoid tumour cell lines obtained from canine patients.
    Tomiyasu H; Goto-Koshino Y; Fujino Y; Ohno K; Tsujimoto H
    Vet J; 2014 Jan; 199(1):103-9. PubMed ID: 24332606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromatin states of developmentally-regulated genes revealed by DNA and histone methylation patterns in zebrafish embryos.
    Lindeman LC; Winata CL; Aanes H; Mathavan S; Alestrom P; Collas P
    Int J Dev Biol; 2010; 54(5):803-13. PubMed ID: 20336603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative epigenome analysis identifies a Polycomb-targeted differentiation program as a tumor-suppressor event epigenetically inactivated in colorectal cancer.
    Tan J; Yang X; Jiang X; Zhou J; Li Z; Lee PL; Li B; Robson P; Yu Q
    Cell Death Dis; 2014 Jul; 5(7):e1324. PubMed ID: 25032847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
    Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
    Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation associated with polycomb repression in retinoic acid receptor β silencing.
    Moison C; Senamaud-Beaufort C; Fourrière L; Champion C; Ceccaldi A; Lacomme S; Daunay A; Tost J; Arimondo PB; Guieysse-Peugeot AL
    FASEB J; 2013 Apr; 27(4):1468-78. PubMed ID: 23299856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma.
    Kikuchi J; Koyama D; Wada T; Izumi T; Hofgaard PO; Bogen B; Furukawa Y
    J Clin Invest; 2015 Oct; 125(12):4375-90. PubMed ID: 26517694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.